Jeff Yass’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,300
| Closed | -$8K | – | 11349 |
|
|
2020
Q1 | $8K | Buy |
11,300
+500
| +5% | +$687 | ﹤0.01% | 10065 |
|
|
2019
Q4 | $16K | Buy |
+10,800
| New | +$16.2K | ﹤0.01% | 9517 |
|
|
2019
Q2 | – | Sell |
-30,500
| Closed | -$80K | – | 11120 |
|
|
2019
Q1 | $80K | Sell |
30,500
-5,700
| -16% | -$13.4K | ﹤0.01% | 8332 |
|
|
2018
Q4 | $60K | Sell |
36,200
-13,100
| -27% | -$36.8K | ﹤0.01% | 8419 |
|
|
2018
Q3 | $239K | Buy |
49,300
+9,900
| +25% | +$56.1K | ﹤0.01% | 7913 |
|
|
2018
Q2 | $246K | Sell |
39,400
-2,600
| -6% | -$19.4K | ﹤0.01% | 8227 |
|
|
2018
Q1 | $349K | Sell |
42,000
-36,700
| -47% | -$350K | ﹤0.01% | 7368 |
|
|
2017
Q4 | $803K | Buy |
78,700
+29,900
| +61% | +$287K | ﹤0.01% | 5687 |
|
|
2017
Q3 | $447K | Buy |
48,800
+24,100
| +98% | +$183K | ﹤0.01% | 6706 |
|
|
2017
Q2 | $180K | Buy |
+24,700
| New | +$186K | ﹤0.01% | 8368 |
|
Jeff Yass's NEOS Position: Q1 2021 in Review
Jeff Yass sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 245,105 shares — an estimated $153K sold.
Jeff Yass first reported a position in NEOS in Q4 2016 and held it in 9 quarters. The position peaked at $2.33M in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Jeff Yass reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Jeff Yass sold 245,105 Neos Therapeutics, Inc shares in Q1 2021, an estimated $153K.
- Jeff Yass first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 9 quarters.
- Jeff Yass's Neos Therapeutics, Inc position peaked at $2.33M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.